What is it about?
The momentous development of antimicrobial resistance in India in Shigella species is highlighted in this article. A general review of antimicrobial resistance and its mechanisms is also given. It also illustrates how resistance develops in various antimicrobial drugs.
Featured Image
Photo by julien Tromeur on Unsplash
Why is it important?
The primary cause of drug therapy's ineffectiveness, which makes treating the disease condition more challenging, is antimicrobial resistance. In this research, we discuss antimicrobial resistance in Shigella spp. in India, including its mechanism and prognostic situation. This will help healthcare provider to provide better outcome and management.
Perspectives
I think it's crucial to pay attention to the threat posed by the global spread of antimicrobial resistance. The issue and reasons of antimicrobial resistance in India are discussed in this article. This study gives healthcare providers access to information about Shigella species' resistance to various antibiotics at a glance and thus helps in enhancing therapy and encouraging the development of new medications.
Mr Deepak Pankajbhai Patel
Saraswati Institute of Pharmaceutical Sciences
Read the Original
This page is a summary of: Study of Antimicrobial Resistance (AMR) in Shigella spp. in India, Recent Advances in Anti-Infective Drug Discovery, August 2024, Bentham Science Publishers,
DOI: 10.2174/0127724344268156231129095108.
You can read the full text:
Resources
Contributors
The following have contributed to this page
